It's been a busy spring at OsoBio. That means we have lots of news and updates to share with you.
First, we're pleased to announce we've been granted research and analytical licenses by the U.S. Drug Enforcement Administration (DEA) to handle Schedule II through V controlled substances.
Of course, we've long handled complex and potent products that require exacting attention and innovative solutions. We're now bringing this experience and expertise to the challenge of controlled substances.
Browse the links here for more of our latest news. And be sure to visit our newly revamped website. We've made it easier for you to navigate and find the information you need. Email Milton Boyer and let us know what you think!
As always, we appreciate the trust you place in us as a manufacturing partner. Please let us know if we can offer any assistance to you in the coming months.